Aerpio Pharma Cincinnati OH
Pharma & Biotech company headquartered in Cincinnati, OH. Cross-border supply chain, facility locations, and freight intelligence below.
Aerpio Therapeutics is a small biopharmaceutical company headquartered in Cincinnati, Ohio, focused on developing novel therapeutics for vascular disorders, particularly diseases of the eye and inflammatory bowel disease. Their lead programs include a Tie2 activator (AKB-9778) for diabetic retinopathy and a HIF-α stabilizer (AKB-4924) for IBD. As of the available data, the company was in clinical-stage drug development with no commercial manufacturing operations identified.
- Industry
- Pharma & Biotech
- Headquarters
- Cincinnati, OH
- Revenue
- $20 million
- US facilities
- Cincinnati, OH
Start a free trial to see Aerpio Pharma Cincinnati OH’s full freight profile — facility network, cross-border lanes, and shipper intelligence.